Frequency of development, type and association with vaccination of adverse events during the study.;GMT on day 21 after the course of vaccination;The frequency of occurrence of clinically significant deviations from the norm of the main indicators of vital functions and laboratory parameters.;Titer of specific antibodies

Frequency of development, type and association with vaccination of adverse events during the study.;GMT on day 21 after the course of vaccination;The frequency of occurrence of clinically significant deviations from the norm of the main indicators of vital functions and laboratory parameters.;Titer of specific antibodies